Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Item No. 42252

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
γ1-Melanocyte-stimulating hormone (γ1-MSH) is a peptide hormone produced by post-translational processing of proopiomelanocortin (POMC) in the pituitary gland.1 It selectively binds to melanocortin receptor 1 (MC1R) and MC3R over MC4R and MC5R (Kis = 0.025, 0.063, >100, and >100 µM, respectively, in insect cells expressing the human receptors) but also binds to opioid receptors in rat brain tissue homogenates (IC50 = 5.9 µM).2,3 γ1-MSH (10 µM) inhibits contractions induced by the neuropeptide FMRF-amide in isolated M. edulis catch muscle.4 Intracisternal administration of γ1-MSH (0.3 nmol/animal) increases the latency to tail flick in the tail-flick test and inhibits haloperidol-induced catalepsy in mice.5 γ1-MSH (0.01 nmol/animal) also inhibits LPS-induced nitric oxide (NO) release in mouse forebrain in vivo.2
WARNING This product is not for human or veterinary use.
1. Profiling signaling peptides in single mammalian cells using mass spectrometry. Anal. Chem. 78(20), 7267-7272 (2006).
2. The MC3 receptor binding affinity of melanocortins correlates with the nitric oxide production inhibition in mice brain inflammation model. Peptides 27(6), 1443-1450 (2006).
3. 'γ-
4. Pharmacology of FMRFamide in Mytilus catch muscle. Comp. Biochem. Physiol. C Comp. Pharmacol. Toxicol. 85(1), 207-214 (1986).
5. The γ2-